Eston Norwood
Neurology · Decatur, ALNPI 1639170095
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations.
Across 217 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$593
- AbbVie$535
- AstraZeneca$225
- Teva Pharmaceuticals USA, Inc.$219
- Kyowa Kirin, Inc.$191
- EMD Serono, Inc.$191
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$632%
- Food & beverage$3,50398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 44 | $593 |
| AbbVie(2 entities) | 40 | $535 |
| AstraZeneca | 12 | $225 |
| Teva Pharmaceuticals USA, Inc. | 15 | $219 |
| Kyowa Kirin, Inc. | 8 | $191 |
| EMD Serono, Inc. | 9 | $191 |
| Lilly USA, LLC | 10 | $191 |
| Lundbeck LLC | 9 | $160 |
| Sunovion Pharmaceuticals Inc. | 7 | $143 |
| SK Life Science, Inc. | 7 | $140 |
| Biohaven Pharmaceuticals, Inc. | 5 | $118 |
| Supernus Pharmaceuticals, Inc. | 5 | $94 |
| GE HealthCare | 6 | $89 |
| Amneal Pharmaceuticals LLC | 5 | $77 |
| Biogen | 4 | $67 |
| Acorda Therapeutics, Inc | 3 | $63 |
| Avanir Pharmaceuticals, Inc. | 5 | $62 |
| Greenwich Biosciences, Inc. | 4 | $62 |
| Eisai Inc. | 3 | $54 |
| Acadia Pharmaceuticals Inc | 3 | $50 |
| Adamas Pharmaceuticals, Inc. | 2 | $48 |
| MDD US Operations, LLC | 2 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Amgen | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Harmony Biosciences LLC | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Novartis | 1 | $14 |
| Livanova USA, Inc. | 1 | $13 |
How this compares
$3,566 in reported general payments places this provider in the 55th percentile of 255 neurology providers in Alabama.
Other neurology in Decatur
- Diane CounceBirmingham$895K
- Daniel DeesMobile$799K
- Christopher LagankeCullman$711K
- Hayden LongMobile$386K
- Harry McDarisHuntsville$307K
- Belinda Savage-EdwardsHuntsville$296K
- Emily RiserBirmingham$231K
- Nojan ValadiOpelika$219K
- Charles MarkleMobile$212K
- Timothy PrestleyTuscaloosa$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.